Literature DB >> 19050069

Allogeneic stem cell transplantation for thalassemia major.

Emanuele Angelucci, Donatella Baronciani.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19050069     DOI: 10.3324/haematol.2008.001909

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT).

Authors:  Michael J Kelly; Brian W Pennarola; Angie Mae Rodday; Susan K Parsons
Journal:  Pediatr Blood Cancer       Date:  2011-12-19       Impact factor: 3.167

2.  Second bone marrow transplantation for patients with thalassemia: risks and benefits.

Authors:  Polina Stepensky; Reuven Or; Michael Y Shapira; Shoshana Revel-Vilk; Jerry Stein; Igor B Resnick
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 3.  Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.

Authors:  Alok Srivastava; Ramachandran V Shaji
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

4.  Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.

Authors:  N A Fouzia; E S Edison; K M Lakshmi; A Korula; S R Velayudhan; P Balasubramanian; A Abraham; A Viswabandya; B George; V Mathews; A Srivastava
Journal:  Bone Marrow Transplant       Date:  2017-10-16       Impact factor: 5.483

5.  Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Authors:  Emanuele Angelucci; Susanne Matthes-Martin; Donatella Baronciani; Françoise Bernaudin; Sonia Bonanomi; Maria Domenica Cappellini; Jean-Hugues Dalle; Paolo Di Bartolomeo; Cristina Díaz de Heredia; Roswitha Dickerhoff; Claudio Giardini; Eliane Gluckman; Ayad Achmed Hussein; Naynesh Kamani; Milen Minkov; Franco Locatelli; Vanderson Rocha; Petr Sedlacek; Frans Smiers; Isabelle Thuret; Isaac Yaniv; Marina Cavazzana; Christina Peters
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

6.  HLA-matched sibling bone marrow transplantation for β-thalassemia major.

Authors:  Mitchell Sabloff; Mammen Chandy; Zhiwei Wang; Brent R Logan; Ardeshir Ghavamzadeh; Chi-Kong Li; Syed Mohammad Irfan; Christopher N Bredeson; Morton J Cowan; Robert Peter Gale; Gregory A Hale; John Horan; Suradej Hongeng; Mary Eapen; Mark C Walters
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

Review 7.  Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Authors:  A Sureda; P Bader; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; J C Marsh; A Nagler; C Peters; A Velardi; M Mohty; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

8.  Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.

Authors:  Marco Andreani; Manuela Testi; Mariarosa Battarra; Guido Lucarelli
Journal:  Chimerism       Date:  2011-01

Review 9.  A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.

Authors:  Shayma Ahmed; Ashraf Soliman; Vincenzo De Sanctis; Nada Alaaraj; Fawzia Alyafei; Noor Hamed; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-08-31

10.  Hematopietic stem cell transplantation in thalassemia and related disorders.

Authors:  Emanuele Angelucci; Federica Pilo; Clara Targhetta; Martina Pettinau; Cristina Depau; Claudia Cogoni; Sara Usai; Mario Pani; Laura Dessì; Donatella Baronciani
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-03       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.